GENEVA, April 15 -- ASPIRE BIOPHARMA HOLDINGS, INC. (23150 Fashion Drive, Suite 232Estero, Florida 33928) filed a patent application (PCT/US2025/049281) for "ORAL MUCOSAL FORMULATIONS OF ASPIRIN" on Oct 02, 2025. With publication no. WO/2026/076270, the details related to the patent application was published on Apr 09, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): DZANDU, James (23150 Fashion Drive, Suite 232Estero, Florida 33928)
Abstract: Disclosed herein, in part, are pharmaceutical formulations for oral mucosal (e.g., sublingual and/or buccal) administration comprising micronized aspi...